Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft

Transpl Int. 2012 Aug;25(8):e93-5. doi: 10.1111/j.1432-2277.2012.01497.x. Epub 2012 May 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Atypical Hemolytic Uremic Syndrome
  • Female
  • Graft Rejection
  • Hemolytic-Uremic Syndrome / drug therapy*
  • Humans
  • Kidney Transplantation / adverse effects*
  • Plasma Exchange
  • Recurrence

Substances

  • Antibodies, Monoclonal, Humanized
  • eculizumab